Oppenheimer Has Lowered Expectations for Bioceres Crop Solutions (NASDAQ:BIOX) Stock Price

Bioceres Crop Solutions (NASDAQ:BIOX) had its price objective reduced by stock analysts at Oppenheimer from $13.00 to $12.00 in a research note issued to investors on Tuesday,Benzinga reports. The brokerage currently has an “outperform” rating on the stock. Oppenheimer’s target price would suggest a potential upside of 71.43% from the company’s current price.

Separately, Canaccord Genuity Group dropped their price objective on shares of Bioceres Crop Solutions from $10.00 to $9.50 and set a “buy” rating for the company in a research note on Wednesday, November 13th. Four investment analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the company currently has a consensus rating of “Buy” and a consensus price target of $11.88.

Bioceres Crop Solutions Stock Up 1.9 %

Shares of BIOX opened at $7.00 on Tuesday. Bioceres Crop Solutions has a 52 week low of $5.71 and a 52 week high of $14.05. The firm has a market capitalization of $438.97 million, a P/E ratio of 350.18 and a beta of 0.56. The company has a 50-day simple moving average of $6.66 and a 200-day simple moving average of $8.04. The company has a debt-to-equity ratio of 0.37, a quick ratio of 0.87 and a current ratio of 1.27.

Bioceres Crop Solutions (NASDAQ:BIOX) last announced its quarterly earnings data on Monday, November 11th. The company reported ($0.09) EPS for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.11). The firm had revenue of $92.60 million during the quarter, compared to the consensus estimate of $117.15 million. Bioceres Crop Solutions had a return on equity of 0.68% and a net margin of 0.53%. During the same quarter in the prior year, the business posted ($0.07) EPS. On average, equities research analysts expect that Bioceres Crop Solutions will post 0.12 earnings per share for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of BIOX. Stifel Financial Corp grew its holdings in shares of Bioceres Crop Solutions by 33.4% in the 3rd quarter. Stifel Financial Corp now owns 40,790 shares of the company’s stock worth $321,000 after purchasing an additional 10,224 shares during the last quarter. Ping Capital Management Inc. boosted its position in Bioceres Crop Solutions by 7.3% in the fourth quarter. Ping Capital Management Inc. now owns 44,000 shares of the company’s stock valued at $268,000 after buying an additional 3,000 shares in the last quarter. Dimensional Fund Advisors LP increased its holdings in shares of Bioceres Crop Solutions by 9.5% during the second quarter. Dimensional Fund Advisors LP now owns 61,330 shares of the company’s stock worth $688,000 after buying an additional 5,341 shares in the last quarter. JPMorgan Chase & Co. raised its stake in shares of Bioceres Crop Solutions by 49.3% in the third quarter. JPMorgan Chase & Co. now owns 89,973 shares of the company’s stock valued at $708,000 after acquiring an additional 29,693 shares during the last quarter. Finally, Fourth Sail Capital LP boosted its holdings in shares of Bioceres Crop Solutions by 61.6% in the 3rd quarter. Fourth Sail Capital LP now owns 3,171,102 shares of the company’s stock worth $24,957,000 after acquiring an additional 1,209,277 shares in the last quarter. 17.68% of the stock is currently owned by institutional investors and hedge funds.

About Bioceres Crop Solutions

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.